Efficacy of Ketamine for Opioid-Free Anesthesia (OFA) in Patients Undergoing Mastectomy: A Randomized Controlled Trial.

Q3 Medicine
Aishwarya Ramkrishnan, Nivedhyaa Srinivasaraghavan, Punitha Chockalingam, Kalpana Balakrishnan, Prasanna V Vanmayil
{"title":"Efficacy of Ketamine for Opioid-Free Anesthesia (OFA) in Patients Undergoing Mastectomy: A Randomized Controlled Trial.","authors":"Aishwarya Ramkrishnan, Nivedhyaa Srinivasaraghavan, Punitha Chockalingam, Kalpana Balakrishnan, Prasanna V Vanmayil","doi":"10.6859/aja.202506_63(2).0004","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Opioid-free anesthesia (OFA) is an emerging practice in cancer care, providing adequate analgesia with reduced side effects. The objective of the study is to evaluate whether ketamine can replace morphine for performing OFA by assessing the acute pain relief achieved and to evaluate its effect on chronic pain.</p><p><strong>Methods: </strong>A total of 182 women undergoing modified radical mastectomy were recruited and randomized into the morphine group and the ketamine group. Participants in the morphine group received 0.05 mg/kg morphine 20 minutes before induction, and those in the ketamine group received 0.40 mg/kg bolus and 1.00 mg/kg/hour ketamine infusion until axillary dissection. The numerical rating pain scale (NRS) at 0, 2, 6, 12, and 24 hours postsurgery was recorded, and the Revised American Pain Society Patient Outcome Questionnaire (APS-POQ-R) was filled out the next day. The chronic pain score at 3 and 6 months after surgery was noted.</p><p><strong>Results: </strong>The mean NRS at 24 hours was 2.385 ± 0.965 in the ketamine group and 2.240 ± 0.996 in the morphine group (P = 0.336). The APS-POQ-R showed that, on average, patients in the ketamine group and the morphine group experienced moderate to severe pain for and 28.00% and 27.72% of the time in a day, respectively, and rescue analgesia usage was also comparable. The incidence of chronic pain was 28.9% and 21.2% (P = 0.31) at 3 months and 32.1% and 21.2 % (P = 0.19) at 6 months in the ketamine group and the morphine group, respectively, and not statistically significant.</p><p><strong>Conclusion: </strong>The results demonstrated that both ketamine and morphine provided similar levels of acute pain relief during the procedure, with no significant difference in pain outcomes between the two groups. These findings suggest that ketamine may be a viable alternative to morphine in the management of pain during OFA, with similar efficacy in both acute and chronic pain relief.</p>","PeriodicalId":8482,"journal":{"name":"Asian journal of anesthesiology","volume":"63 2","pages":"70-79"},"PeriodicalIF":0.0000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asian journal of anesthesiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.6859/aja.202506_63(2).0004","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Opioid-free anesthesia (OFA) is an emerging practice in cancer care, providing adequate analgesia with reduced side effects. The objective of the study is to evaluate whether ketamine can replace morphine for performing OFA by assessing the acute pain relief achieved and to evaluate its effect on chronic pain.

Methods: A total of 182 women undergoing modified radical mastectomy were recruited and randomized into the morphine group and the ketamine group. Participants in the morphine group received 0.05 mg/kg morphine 20 minutes before induction, and those in the ketamine group received 0.40 mg/kg bolus and 1.00 mg/kg/hour ketamine infusion until axillary dissection. The numerical rating pain scale (NRS) at 0, 2, 6, 12, and 24 hours postsurgery was recorded, and the Revised American Pain Society Patient Outcome Questionnaire (APS-POQ-R) was filled out the next day. The chronic pain score at 3 and 6 months after surgery was noted.

Results: The mean NRS at 24 hours was 2.385 ± 0.965 in the ketamine group and 2.240 ± 0.996 in the morphine group (P = 0.336). The APS-POQ-R showed that, on average, patients in the ketamine group and the morphine group experienced moderate to severe pain for and 28.00% and 27.72% of the time in a day, respectively, and rescue analgesia usage was also comparable. The incidence of chronic pain was 28.9% and 21.2% (P = 0.31) at 3 months and 32.1% and 21.2 % (P = 0.19) at 6 months in the ketamine group and the morphine group, respectively, and not statistically significant.

Conclusion: The results demonstrated that both ketamine and morphine provided similar levels of acute pain relief during the procedure, with no significant difference in pain outcomes between the two groups. These findings suggest that ketamine may be a viable alternative to morphine in the management of pain during OFA, with similar efficacy in both acute and chronic pain relief.

氯胺酮用于乳腺切除术患者无阿片类麻醉(OFA)的疗效:一项随机对照试验。
背景:无阿片类药物麻醉(OFA)在癌症治疗中是一种新兴的做法,提供充分的镇痛和减少副作用。本研究的目的是通过评估氯胺酮对急性疼痛的缓解效果和对慢性疼痛的影响来评估氯胺酮是否可以替代吗啡进行OFA。方法:选取182例行改良乳房根治术的妇女,随机分为吗啡组和氯胺酮组。吗啡组在诱导前20分钟注射0.05 mg/kg吗啡,氯胺酮组注射0.40 mg/kg氯胺酮及1.00 mg/kg氯胺酮至腋清扫。记录术后0、2、6、12、24小时的数值评定疼痛量表(NRS),并于次日填写修订后的美国疼痛学会患者结局问卷(APS-POQ-R)。记录术后3个月和6个月的慢性疼痛评分。结果:氯胺酮组24 h平均NRS为2.385±0.965,吗啡组平均NRS为2.240±0.996 (P = 0.336)。APS-POQ-R显示,氯胺酮组和吗啡组患者平均每天出现中至重度疼痛的时间分别为28.00%和27.72%,镇痛药物的使用情况也相当。氯胺酮组和吗啡组3个月时慢性疼痛发生率分别为28.9%和21.2% (P = 0.31), 6个月时分别为32.1%和21.2% (P = 0.19),差异无统计学意义。结论:结果表明氯胺酮和吗啡在手术过程中提供了相似的急性疼痛缓解水平,两组之间的疼痛结局无显著差异。这些发现表明氯胺酮可能是吗啡在OFA期间疼痛管理的可行替代品,在急性和慢性疼痛缓解方面具有相似的疗效。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Asian journal of anesthesiology
Asian journal of anesthesiology Medicine-Medicine (all)
CiteScore
1.00
自引率
0.00%
发文量
38
期刊介绍: Asian Journal of Anesthesiology (AJA), launched in 1962, is the official and peer-reviewed publication of the Taiwan Society of Anaesthesiologists. It is published quarterly (March/June/September/December) by Airiti and indexed in EMBASE, Medline, Scopus, ScienceDirect, SIIC Data Bases. AJA accepts submissions from around the world. AJA is the premier open access journal in the field of anaesthesia and its related disciplines of critical care and pain in Asia. The number of Chinese anaesthesiologists has reached more than 60,000 and is still growing. The journal aims to disseminate anaesthesiology research and services for the Chinese community and is now the main anaesthesiology journal for Chinese societies located in Taiwan, Mainland China, Hong Kong and Singapore. AJAcaters to clinicians of all relevant specialties and biomedical scientists working in the areas of anesthesia, critical care medicine and pain management, as well as other related fields (pharmacology, pathology molecular biology, etc). AJA''s editorial team is composed of local and regional experts in the field as well as many leading international experts. Article types accepted include review articles, research papers, short communication, correspondence and images.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书